Based in Birkerod, Denmark, Mr Moraviec will have global responsibility for the continence and critical care business unit, a new business unit formed following ConvaTec’s integration of Unomedical, a manufacturer of single-use medical devices. Additionally, he will have responsibility for the EMEA region. As president, Mr Moraviec will join the company’s executive committee.
Prior to joining ConvaTec, Mr Moraviec was CEO of Prosurgics, a surgical robotics company. Prior to this, he held the position of vice president of international commercial operations for Abbott Laboratories diabetes care division.
David Johnson, CEO of ConvaTec, said: “Paul is a proven leader with an outstanding track record of driving growth across a number of medical device specialties, making him the ideal person to leverage the newly combined product portfolio for further penetration into the acute care and home healthcare settings. With Paul’s appointment, we now have the team in place to fully capitalize on the opportunities ahead and lead ConvaTec in achieving our goal of becoming the growth leader in each of our markets and key business areas.”